Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Marcel

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
The American Journal of Cardiology|September 20, 2005
Impact of beta-blocker therapy at discharge on long-term mortality after primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Menko-Jan de Boer, Jan Paul Ottervanger, et al.
The American Journal of Cardiology|June 14, 2005
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
Atherosclerosis|July 11, 2006
Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
European Journal of Heart Failure|June 12, 2003
The prognostic importance of heart failure and age in patients treated with primary angioplastyJose P S Henriques, Felix Zijlstra, Menko-Jan de Boer, et al.
European Heart Journal|February 1, 2005
Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Arnoud W J van 't Hof, Jan Paul Ottervanger, et al.
Coronary Artery Disease|December 4, 2008
Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarctionMark B Nienhuis, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarctionRenicus S Hermanides, Jan-Paul Ottervanger, Jan-Henk E Dambrink, et al.
BMC Cardiovascular Disorders|March 7, 2007
Are patients with non-ST elevation myocardial infarction undertreated?Saman Rasoul, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
Journal of the American College of Cardiology|April 20, 2004
Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Felix Zijlstra, et al.
Coronary Artery Disease|July 31, 2009
Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarctionSaman Rasoul, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
The American Journal of Cardiology|September 20, 2005
Impact of beta-blocker therapy at discharge on long-term mortality after primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Menko-Jan de Boer, Jan Paul Ottervanger, et al.
The American Journal of Cardiology|June 14, 2005
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
Atherosclerosis|July 11, 2006
Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
European Journal of Heart Failure|June 12, 2003
The prognostic importance of heart failure and age in patients treated with primary angioplastyJose P S Henriques, Felix Zijlstra, Menko-Jan de Boer, et al.
European Heart Journal|February 1, 2005
Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Arnoud W J van 't Hof, Jan Paul Ottervanger, et al.
Coronary Artery Disease|December 4, 2008
Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarctionMark B Nienhuis, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarctionRenicus S Hermanides, Jan-Paul Ottervanger, Jan-Henk E Dambrink, et al.
BMC Cardiovascular Disorders|March 7, 2007
Are patients with non-ST elevation myocardial infarction undertreated?Saman Rasoul, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
Journal of the American College of Cardiology|April 20, 2004
Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Felix Zijlstra, et al.
Coronary Artery Disease|July 31, 2009
Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarctionSaman Rasoul, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Pageof 9